Home / Research library / Agomelatine Powder
Agomelatine Powder: molecular data, studies & sources
Agomelatine Powder is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C15H17NO2
- Molecular weight (MW)
- 243.30 g/mol
- PubChem compound ID
- 82148
- Record title
- Agomelatine
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 82148 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
- InChIKey
- YJYPHIXNFHFHND-UHFFFAOYSA-N
- SMILES
- CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
Efficacy and Safety of Electroacupuncture Combined with Agomelatine Tablets Therapy in Treating Insomnia After Stroke.
Han R, Wei W · Journal of molecular neuroscience : MN · 2025
PMID 40782216 · DOI: 10.1007/s12031-025-02394-9
- Human study · PubMed trial index
Agomelatine but not melatonin improves fatigue perception: a longitudinal proof-of-concept study.
Pardini M, Cordano C, Benassi F et al. · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2014
PMID 24636462 · DOI: 10.1016/j.euroneuro.2014.02.010
- Human study · PubMed trial index
Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine.
Liang Z, Jia Y, Zhao L et al. · Aging · 2021
PMID 34610580 · DOI: 10.18632/aging.203586
- Human study · PubMed trial index
Antidepressant effect in older depressed patients: the lessons of two agomelatine trials.
Goodwin GM, Thomas P, Heun R et al. · International clinical psychopharmacology · 2017
PMID 28383308 · DOI: 10.1097/YIC.0000000000000174
- Human study · PubMed trial index
Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms.
Martinotti G, Pettorruso M, De Berardis D et al. · The international journal of neuropsychopharmacology · 2016
PMID 26775293 · DOI: 10.1093/ijnp/pyw003
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
[Agomelatine].
Tessmer M · Medizinische Monatsschrift fur Pharmazeuten · 2009
PMID 19777735
- Review · secondary evidence
Agomelatine in depression.
Smeraldi E, Delmonte D · Expert opinion on drug safety · 2013
PMID 24033095 · DOI: 10.1517/14740338.2013.828690
- Review · secondary evidence
Focus on agomelatine.
Green B · Current medical research and opinion · 2011
PMID 21271795 · DOI: 10.1185/03007995.2011.554534
Agomelatine Powder supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all Agomelatine Powder sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 1000mg Powder1 recorded offers | 1000mg Powder · $36.00Checked Sep 16, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 82148 — chemical identity and structure.
- Wikipedia: Agomelatine — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Adalank Spray
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
Adamax
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
Cerebrolysin
Molecular identity needs further verification
7 selected publications · 5 human study records
Dihexa
C27H44N4O5
504.7 g/mol · PubChem CID 129010512
0 selected publications · 0 human study records
Fasoracetam Powder
C10H16N2O2
196.25 g/mol · PubChem CID 198695
3 selected publications · 1 human study records
ISRIB Powder
C22H24Cl2N2O4
451.3 g/mol · PubChem CID 1011240
3 selected publications · 0 human study records